Oxygen Biotherapeutics Mission & Goals
News & Events
Oxygen Biotherapeutics to Host 2013 Annual Meeting of Shareholders
MORRISVILLE, N.C.--(BUSINESS WIRE)--Dec. 3, 2013-- Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a developer of oxygen-carrying therapeutics, today announced it will webcast its 2013 Annual Meeting of Shareholders on Wednesday, December 4, 2013 beginning at 9:00am ET at the offices of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P. located at Wells Fargo Capitol Center, 150 Fayettville Street, Suite 2300, Raleigh, NC 27601. Oxygen Biotherapeutics’ CEO John Kelley and CFO Michael Jebsen will be hosting the call.
A listen only teleconference will be available in real-time by dialing (877) 836-0197. To listen to the live webcast, please access the link https://event.webcasts.com/starthere.jsp?ei=1026689, at least 15 minutes prior to register. A replay of the call will be made available until June 4, 2014. more..
- To participate in our annual share holder meeting, call 877-836-0197 OR you can participate via webcast
- News and Events
- Press Releases
The mission of Oxygen Biotherapeutics is to research, develop and market oxygen related products based on our perfluorocarbon technology. Our dedicated team is driven by the promise of utilizing perfluorocarbons for maintaining health and improving quality of life through improved oxygen delivery to tissues and organs.